Close Menu

NEW YORK – CareDx and Johns Hopkins University announced on Thursday a partnership to launch the Allosure Lung Allograft Remote Monitoring (ALARM) Partnership.

During the COVID-19 pandemic, Johns Hopkins has adopted CareDx's RemoTraC for high-risk populations of kidney, heart, and lung transplant patients who need close medical monitoring. RemoTraC is a remote home-based blood draw product that uses mobile phlebotomy for AlloSure and AlloMap surveillance tests, as well as for other standard monitoring tests.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.